No CrossRef data available.
Article contents
Effect of vitamin D supplementation for major adverse cardiovascular events: a meta-analysis based on randomised controlled trials
Published online by Cambridge University Press: 21 July 2025
Abstract
This meta-analysis assesses the relationship between vitamin D supplementation and incidence of major adverse cardiovascular events (MACE). PubMed, Web of science, Ovid, Cochrane Library and Clinical Trials were used to systematically search from their inception until July 2024. Hazard ratios (HR) and 95 % CI were employed to assess the association between vitamin D supplementation and MACE. This analysis included five randomised controlled trials (RCT). Pooled results showed no significant difference in the incidence of MACE (HR: 0·96; P = 0·77) and expanded MACE (HR: 0·96; P = 0·77) between the vitamin D intervention group and the control group. Further, the vitamin D intervention group had a lower incidence of myocardial infarction (MI), but the difference was not statistically significant (HR: 0·88, 95 % CI: 0·77, 1·01; P = 0·061); nevertheless, vitamin D supplementation had no effect on the reduced incidence of stroke (P = 0·675) or cardiovascular death (P = 0·422). Among males (P = 0·109) and females (P = 0·468), vitamin D supplementation had no effect on the reduced incidence of MACE. For participants with a BMI < 25 kg/m2, the difference was not statistically significant (P = 0·782); notably, the vitamin D intervention group had a lower incidence of MACE for those with BMI ≥ 25 kg/m2 (HR: 0·91, 95 % CI: 0·83, 1·00; P = 0·055). Vitamin D supplementation did not significantly contribute to the risk reduction of MACE, stroke and cardiovascular death in the general population, but may be helpful for MI. Notably, the effect of vitamin D supplementation for MACE was influenced by BMI. Overweight/obese people should be advised to take vitamin D to reduce the incidence of MACE.
Information
- Type
- Systematic Review and Meta-Analysis
- Information
- Copyright
- © The Author(s), 2025. Published by Cambridge University Press on behalf of the Nutrition Society
References
Roth, GA, Mensah, GA, Johnson, CO, et al. (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76, 2982–3021.CrossRefGoogle ScholarPubMed
Joynt Maddox, KE, Elkind, MSV, Aparicio, HJ, et al. (2024) Forecasting the burden of cardiovascular disease and stroke in the United States through 2050-prevalence of risk factors and disease: a presidential advisory from the American Heart Association. Circulation 150, e65–e88.CrossRefGoogle ScholarPubMed
Arnett, DK, Blumenthal, RS, Albert, MA, et al. (2019) 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 140, e596–e646.Google Scholar
Wimalawansa, SJ (2018) Vitamin D and cardiovascular diseases: causality. J Steroid Biochem Mol Biol 175, 29–43.CrossRefGoogle ScholarPubMed
Kim, DH, Sabour, S, Sagar, UN, et al. (2008) Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 102, 1540–1544.CrossRefGoogle ScholarPubMed
Thompson, B, Waterhouse, M, English, DR, et al. (2023) Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ (Clin Res Ed) 381, e075230.Google ScholarPubMed
Ye, H, Li, Y, Liu, S, et al. (2024) Association between serum 25-hydroxyvitamin D and vitamin D dietary supplementation and risk of all-cause and cardiovascular mortality among adults with hypertension. Nutr J 23, 33.CrossRefGoogle ScholarPubMed
Mattumpuram, J, Maniya, MT, Faruqui, SK, et al. (2024) Cardiovascular and cerebrovascular outcomes with vitamin D supplementation: a systematic review and meta-analysis. Curr Prob Cardiol 49, 102119.CrossRefGoogle ScholarPubMed
Pei, YY, Zhang, Y, Peng, XC, et al. (2022) Association of vitamin D supplementation with cardiovascular events: a systematic review and meta-analysis. Nutrients 14, 3158.CrossRefGoogle ScholarPubMed
Rossello, X, Pocock, SJ & Julian, DG (2015) Long-term use of cardiovascular drugs: challenges for research and for patient care. J Am Coll Cardiol 66, 1273–1285.CrossRefGoogle ScholarPubMed
Page, MJ, McKenzie, JE, Bossuyt, PM, et al. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed) 372, n71.Google ScholarPubMed
Bosco, E, Hsueh, L, McConeghy, KW, et al. (2021) Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Method 21, 241.CrossRefGoogle ScholarPubMed
Virtanen, JK, Nurmi, T, Aro, A, et al. (2022) Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial. Am J Clin Nutr 115, 1300–1310.CrossRefGoogle ScholarPubMed
Scragg, R, Stewart, AW, Waayer, D, et al. (2017) Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial. JAMA Cardiol 2, 608–616.CrossRefGoogle ScholarPubMed
Manson, JE, Bassuk, SS & Buring, JE (2020) Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J Steroid Biochem Mol Biol 198, 105522.CrossRefGoogle ScholarPubMed
Desouza, C, Chatterjee, R, Vickery, EM, et al. (2022) The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: a secondary analysis of the D2d study. J Diabetes Complications 36, 108230.CrossRefGoogle ScholarPubMed
Cui, C, Xu, P, Li, G, et al. (2019) Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system. Redox Biol 26, 101295.CrossRefGoogle ScholarPubMed
Li, YC, Kong, J, Wei, M, et al. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110, 229–238.CrossRefGoogle ScholarPubMed
Mora, JR, Iwata, M & von Andrian, UH (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8, 685–698.CrossRefGoogle Scholar
Chen, Y, Kong, J, Sun, T, et al. (2011) 1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation. Arch Biochem Biophys 507, 241–247.CrossRefGoogle ScholarPubMed
Zhang, R, Li, B, Gao, X, et al. (2017) Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr 105, 810–819.CrossRefGoogle ScholarPubMed
Mandarino, NR, Júnior, F, Salgado, JV, et al. (2015) Is vitamin D deficiency a new risk factor for cardiovascular disease? Open Cardiovasc Med J 9, 40–49.CrossRefGoogle ScholarPubMed
Park, S & Lee, BK (2012) Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged ≥ 50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract 6, 162–168.CrossRefGoogle Scholar
Rahman, A, Hershey, S, Ahmed, S, et al. (2007) Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 103, 416–419.CrossRefGoogle ScholarPubMed
Tishkoff, DX, Nibbelink, KA, Holmberg, KH, et al. (2008) Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 149, 558–564.CrossRefGoogle ScholarPubMed
Schmidt, N, Brandsch, C, Schutkowski, A, et al. (2014) Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wild-type mice. J Nutr 144, 638–646.CrossRefGoogle ScholarPubMed
Lau, WL, Leaf, EM, Hu, MC, et al. (2012) Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int 82, 1261–1270.CrossRefGoogle ScholarPubMed
Wang, L, Song, Y, Manson, JE, et al. (2012) Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5, 819–829.CrossRefGoogle ScholarPubMed
Bell, NH, Shaw, S & Turner, RT (1984) Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 74, 1540–1544.CrossRefGoogle ScholarPubMed
Tebben, PJ, Milliner, DS, Horst, RL, et al. (2012) Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab 97, E423–E427.CrossRefGoogle ScholarPubMed
Hahn, CN, Baker, E, Laslo, P, et al. (1993) Localization of the human vitamin D 24-hydroxylase gene (CYP24) to chromosome 20q13.2-->q13.3. Cytogenetics Cell Genet 62, 192–193.CrossRefGoogle ScholarPubMed
Scragg, R, Jackson, R, Holdaway, IM, et al. (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19, 559–563.CrossRefGoogle Scholar
Wakasugi, M, Noguchi, T, Inoue, M, et al. (1991) Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins 42, 127–136.CrossRefGoogle ScholarPubMed
Artaza, JN & Norris, KC (2009) Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200, 207–221.CrossRefGoogle ScholarPubMed
Timms, PM, Mannan, N, Hitman, GA, et al. (2002) Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM: Monthly J Assoc Phys 95, 787–796.CrossRefGoogle ScholarPubMed
Garland, CF, Kim, JJ, Mohr, SB, et al. (2014) Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health 104, e43–50.CrossRefGoogle ScholarPubMed
Benjamin, EJ, Virani, SS, Callaway, CW, et al. (2018) Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation 137, e67–e492.CrossRefGoogle ScholarPubMed
Chen, FH, Liu, T, Xu, L, et al. (2018) Association of serum vitamin D level and carotid atherosclerosis: a systematic review and meta-analysis. J Ultrasound Med: Offic J Am Inst Ultrasound Med 37, 1293–1303.CrossRefGoogle ScholarPubMed
Blondon, M, Sachs, M, Hoofnagle, AN, et al. (2013) 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 33, 2639–2645.CrossRefGoogle ScholarPubMed
van Dijk, SC, Sohl, E, Oudshoorn, C, et al. (2015) Non-linear associations between serum 25-OH vitamin D and indices of arterial stiffness and arteriosclerosis in an older population. Age Ageing 44, 136–142.CrossRefGoogle Scholar
Vitezova, A, Cartolano, NS, Heeringa, J, et al. (2015) Vitamin D and the risk of atrial fibrillation--the Rotterdam Study. PloS one 10, e0125161.CrossRefGoogle ScholarPubMed
Haffner, SM & Valdez, RA (1995) Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. Am J Med 98, 40s–47s.CrossRefGoogle ScholarPubMed
Xue, B, Pamidimukkala, J, Lubahn, DB, et al. (2007) Estrogen receptor-α mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circulatory Physiol 292, H1770–H1776.CrossRefGoogle ScholarPubMed
Vlachovsky, SG, Di Ciano, LA, Oddo, EM, et al. (2023) Role of female sex hormones and immune response in salt-sensitive hypertension development: evidence from experimental models. Curr Hypertens Rep 25, 405–419.CrossRefGoogle ScholarPubMed
Ng, M, Fleming, T, Robinson, M, et al. (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 766–781.CrossRefGoogle ScholarPubMed
Afshin, A, Forouzanfar, MH, Reitsma, MB, et al. (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377, 13–27.Google ScholarPubMed
Martos-Moreno, G, Martínez-Villanueva, J, González-Leal, R, et al. (2019) Sex, puberty, and ethnicity have a strong influence on growth and metabolic comorbidities in children and adolescents with obesity: report on 1300 patients (the Madrid Cohort). Pediatr Obes 14, e12565.CrossRefGoogle Scholar
Kubota, M (2019) Hyperuricemia in children and adolescents: present knowledge and future directions. J Nutr Metab 2019, 3480718.CrossRefGoogle ScholarPubMed
Anderson, EL, Howe, LD, Jones, HE, et al. (2015) The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PloS one 10, e0140908.CrossRefGoogle ScholarPubMed
López-Galisteo, JP, Gavela-Pérez, T, Mejorado-Molano, FJ, et al. (2022) Prevalence and risk factors associated with different comorbidities in obese children and adolescents. Endocrinologia, Diabetes Nutricion 69, 566–575.CrossRefGoogle ScholarPubMed
Gutiérrez Medina, S, Gavela-Pérez, T, Domínguez-Garrido, MN, et al. (2015) The influence of puberty on vitamin D status in obese children and the possible relation between vitamin D deficiency and insulin resistance. J Pediatr Endocrinol Metab: JPEM 28, 105–110.CrossRefGoogle ScholarPubMed
Drincic, AT, Armas, LA, Van Diest, EE, et al. (2012) Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20, 1444–1448.CrossRefGoogle ScholarPubMed
Benedik, E (2022) Sources of vitamin D for humans. Int J Vitamin Nutr Res Int Z Vitamin- Ernahrungsforschung J International Vitaminologie Nutrition 92, 118–125.CrossRefGoogle ScholarPubMed
Wortsman, J, Matsuoka, LY, Chen, TC, et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690–693.CrossRefGoogle ScholarPubMed
Wamberg, L, Christiansen, T, Paulsen, SK, et al. (2013) Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss. Int J Obes 37, 651–657.CrossRefGoogle Scholar
Cheng et al. supplementary material 1
Cheng et al. supplementary material
File
474.4 KB
Cheng et al. supplementary material 2
Cheng et al. supplementary material
File
1.1 MB
Cheng et al. supplementary material 3
Cheng et al. supplementary material
File
22.7 KB
Cheng et al. supplementary material 4
Cheng et al. supplementary material
File
20.1 KB